Danaher Corporation

Danaher Corporation

DHR · NYSE · Healthcare / Diagnostics & Research

233.02USD+0.86 (+0.37%)

Price History

Full chart

Market Stats

Previous Close232.16
Open232.99
Day Range229.92 – 233.76
52-Week Range160.31 – 241.35
Volume3.36M
Market Cap157.95B
P/E (TTM)39.70
Forward P/E23.81
EPS5.66
Dividend Yield0.72%
Beta0.80
50-Day Avg212.68
200-Day Avg201.32

About

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMs. Julie Sawyer Montgomery
  • Employees58.00K
  • Headquarters2200 Pennsylvania Avenue N.W., Washington, DC, United States, 20037-1701, USA
  • Websitehttps://www.danaher.com

Leadership

  • Mr. Steven M. RalesCo-Founder & Chairman · b. 1951
  • Ms. Julie Sawyer MontgomeryPresident, CEO & Director · b. 1972
  • Mr. Mitchell P. RalesCo-Founder & Director · b. 1957
  • Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior VP & Chief Science Officer · b. 1962
  • Mr. Matthew R. McGrewExecutive Vice President · b. 1972
  • Mr. Rainer M. BlairSenior Advisor · b. 1964
  • Mr. Christopher Paul RileyExecutive VP of Biotechnology Group & CEO of Cytiva · b. 1974
  • Mr. Matthew E. Gugino C.F.A., CPAExecutive VP & CFO · b. 1983
  • Mr. Christopher M. BoudaVP & Chief Accounting Officer
  • Ms. Rachel Marie Vatnsdal OlsonVice President of Investor Relations

Financials

Income Statement

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue446.00M615.00M714.60M749.10M840.00M831.60M949.00M1.07B1.29B1.49B1.81B2.05B2.91B3.20B3.78B3.78B4.58B5.29B6.89B7.98B9.60B11.03B12.70B11.18B13.20B16.09B18.26B19.12B19.91B14.43B16.88B18.33B17.05B17.91B22.28B29.45B26.64B23.89B23.88B24.57B
Growth (%)-+37.89%+16.20%+4.83%+12.13%-1.00%+14.12%+12.44%+20.77%+15.37%+21.87%+13.20%+41.88%+9.87%+18.16%+0.12%+21.01%+15.66%+30.14%+15.90%+20.18%+14.90%+15.16%-11.91%+18.04%+21.87%+13.49%+4.70%+4.16%-27.52%+16.97%+8.57%-6.99%+5.06%+24.41%+32.17%-9.54%-10.33%-0.06%+2.90%
Cost of Revenue342.40M406.40M462.00M499.10M573.30M601.90M670.30M753.00M889.70M981.10M1.17B1.31B1.71B1.83B2.17B2.34B2.79B3.15B4.00B4.54B5.35B5.99B6.72B5.78B6.58B7.85B8.81B9.13B9.43B6.52B7.50B8.10B7.54B7.93B9.81B11.50B10.46B12.22B9.67B9.60B
Gross Profit103.60M208.60M252.60M250.00M266.70M229.70M278.70M314.10M399.00M505.70M640.70M744.60M1.20B1.36B1.61B1.44B1.79B2.14B2.89B3.45B4.24B5.04B5.97B5.40B6.63B8.24B9.45B9.98B10.49B7.91B9.38B10.23B9.51B9.98B12.47B17.95B16.19B14.03B14.21B14.97B
Gross Margin23.23%33.92%35.35%33.37%31.75%27.62%29.37%29.43%30.96%34.01%35.36%36.30%41.15%42.62%42.66%38.19%39.02%40.41%41.99%43.15%44.22%45.72%47.04%48.30%50.19%51.24%51.74%52.22%52.67%54.83%55.58%55.81%55.75%55.74%55.98%60.95%60.76%58.74%59.50%60.93%
Operating Expense70.60M124.10M148.00M156.00M191.10M194.80M217.70M221.10M253.10M325.40M414.50M477.70M830.80M904.80M1.06B942.41M1.08B1.29B1.80B2.17B2.74B3.31B4.02B3.67B4.39B5.51B6.25B6.62B6.89B5.50B6.40B7.08B6.44B6.62B8.16B9.90B8.65B8.83B9.02B9.83B
Operating Income33.00M84.50M104.60M94.00M75.60M34.90M61.00M93.00M145.90M180.30M226.20M266.90M366.80M458.00M552.15M502.01M701.12M846.00M1.10B1.27B1.51B1.73B1.95B1.73B2.23B2.74B3.20B3.37B3.60B2.42B2.99B3.15B3.07B3.36B4.31B8.05B7.54B5.20B5.18B5.14B
Operating Margin7.40%13.74%14.64%12.55%9.00%4.20%6.43%8.72%11.32%12.13%12.48%13.01%12.60%14.33%14.62%13.27%15.32%15.98%15.92%15.96%15.69%15.66%15.37%15.49%16.92%17.01%17.50%17.62%18.09%16.75%17.69%17.18%18.01%18.77%19.35%27.33%28.29%21.77%21.71%20.91%
EBITDA42.30M98.00M122.20M113.10M101.20M68.10M98.10M133.90M190.50M238.80M294.80M343.00M498.70M584.40M701.87M750.13M824.41M979.43M1.27B1.46B1.74B2.02B2.22B1.89B2.86B3.22B4.01B4.61B4.54B3.06B3.92B4.34B4.28B4.60B6.54B10.01B9.48B5.20B7.28B6.95B
EBITDA Margin9.48%15.93%17.10%15.10%12.05%8.19%10.34%12.55%14.78%16.06%16.27%16.72%17.14%18.28%18.58%19.83%18.01%18.50%18.42%18.24%18.17%18.28%17.47%16.89%21.67%20.04%21.95%24.10%22.81%21.20%23.24%23.68%25.09%25.70%29.36%33.98%35.60%21.77%30.48%28.27%
Net Income8.70M20.10M39.00M61.10M35.70M13.30M31.60M17.70M81.70M108.40M207.80M154.80M182.90M261.60M324.21M297.67M290.39M536.83M746.00M897.80M1.12B1.22B1.32B1.15B1.79B1.97B2.30B2.69B2.60B2.60B2.55B2.49B2.65B2.56B3.65B6.43B7.21B4.74B3.90B3.61B
Net Income Margin1.95%3.27%5.46%8.16%4.25%1.60%3.33%1.66%6.34%7.29%11.47%7.55%6.29%8.18%8.58%7.87%6.34%10.14%10.83%11.24%11.69%11.07%10.38%10.30%13.58%12.25%12.59%14.10%13.05%17.99%15.13%13.60%15.55%14.28%16.36%21.84%27.06%19.85%16.33%14.71%
R&D--------------138.00M119.00M174.00M207.00M294.00M379.00M446.00M601.42M725.44M632.65M809.48M1.02B1.14B1.25B1.31B861.40M975.10M1.13B1.06B1.13B1.35B1.74B1.53B1.50B1.58B1.60B
R&D as % of Total Revenue--------------3.65%3.15%3.80%3.91%4.27%4.75%4.65%5.45%5.71%5.66%6.13%6.33%6.23%6.54%6.60%5.97%5.78%6.16%6.21%6.29%6.05%5.91%5.74%6.29%6.63%6.50%
Interest Expense000000000000000043.65M054.98M44.93M79.83M109.70M130.17M122.66M120.78M141.64M157.50M145.90M122.70M139.80M184.40M162.70M136.90M108.60M273.00M241.00M207.00M286.00M278.00M265.00M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.95%0.00%0.80%0.56%0.83%0.99%1.03%1.10%0.91%0.88%0.86%0.76%0.62%0.97%1.09%0.89%0.80%0.61%1.23%0.82%0.78%1.20%1.16%1.08%

Balance Sheet

Currency: USD1986-12-311987-12-311988-12-311989-12-311990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets740.70M655.30M575.80M507.20M744.50M735.00M769.80M872.50M1.13B1.49B1.77B1.88B2.74B3.05B4.03B4.82B6.03B6.89B8.49B9.16B12.86B17.47B17.49B19.60B22.22B29.95B32.94B34.67B36.99B48.22B45.30B46.65B47.83B62.08B76.16B83.18B84.35B84.49B77.54B83.46B
Total Liabilities675.50M552.00M420.10M315.50M439.50M415.70M421.40M508.80M658.80M899.70M964.80M962.80M1.39B1.34B2.09B2.59B3.02B3.24B3.87B4.08B6.22B8.39B7.68B7.97B8.44B12.98B13.86B12.22B13.54B24.46B22.22B20.28B19.61B31.80B36.38B38.01B34.26B31.00B27.99B30.93B
Total Equity65.20M103.30M155.70M191.70M305.00M319.30M348.40M363.70M476.10M586.30M800.30M916.90M1.35B1.71B1.94B2.23B3.01B3.65B4.62B5.08B6.64B9.09B9.81B11.63B13.71B16.90B19.02B22.39B23.38B23.69B23.00B26.36B28.21B30.27B39.77B45.17B50.08B53.49B49.54B52.53B
Cash46.50M13.00M24.10M4.80M600.00K-1.70M6.80M2.00M7.90M26.40M33.30M41.90M260.30M176.92M706.56M810.46M1.23B609.12M315.55M317.81M239.11M392.85M1.72B1.63B537.00M1.68B3.12B3.01B790.80M963.70M630.30M787.80M19.91B6.04B2.59B6.00B5.86B2.08B4.62B
Total Debt489.00M394.60M248.40M143.70M187.00M184.50M168.80M133.60M185.30M283.60M236.40M198.20M472.50M374.60M795.19M1.19B1.31B1.30B1.35B1.04B2.43B3.73B2.62B2.93B2.82B5.31B5.34B3.50B3.47B12.87B12.27B10.52B9.74B22.53B22.18B23.27B20.62B19.54B17.15B18.42B
Net Debt442.50M381.60M224.30M138.90M186.40M184.50M167.10M126.80M183.30M275.70M210.00M164.90M430.60M114.30M618.27M485.13M499.50M68.73M741.18M726.17M2.12B3.49B2.23B1.21B1.19B4.77B3.66B383.80M467.80M12.08B11.31B9.89B8.95B2.61B16.14B20.69B14.62B13.67B15.07B13.80B

Cash Flow

Currency: USD1990-12-311991-12-311992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow70.00M41.80M72.90M135.80M144.40M174.20M217.10M278.40M331.30M419.10M512.25M608.47M710.35M861.54M1.03B1.20B1.55B1.65B1.86B1.80B2.08B2.63B3.42B3.59B3.76B3.80B3.52B3.48B4.02B3.95B6.21B8.36B8.52B7.16B6.69B6.42B
Investing Cash Flow-33.00M-41.80M-56.40M-94.30M-198.70M-267.10M-142.70M-210.00M-599.70M-153.70M-795.30M-487.57M-1.14B-368.05M-1.63B-965.41M-2.77B-3.45B-567.40M-942.94M-2.29B-5.85B-1.89B-552.50M-3.44B-14.95B-5.24B-843.40M-2.95B-1.24B-21.24B-12.99B-2.23B-7.08B-1.98B-1.20B
Financing Cash Flow-39.50M-500.00K-14.90M-36.40M49.30M97.20M-56.10M-61.30M238.30M-51.80M200.48M409.71M516.30M-110.34M-38.05M-511.56M1.22B1.71B-1.12B407.23M116.80M2.09B-388.40M-1.61B-218.20M9.05B2.04B-3.10B-797.00M16.37B1.01B1.29B-2.57B-273.00M-8.38B-2.96B
Capital Expenditure33.00M41.80M33.90M40.30M54.50M59.20M51.30M62.80M616.00M153.70M88.50M80.58M65.43M80.34M115.91M121.21M137.71M162.07M193.78M188.55M217.33M334.47M458.30M538.10M465.40M512.90M589.60M570.70M584.00M635.50M791.00M1.29B1.15B1.38B1.39B1.16B
Free Cash Flow37.00M-39.00M95.50M89.90M115.00M165.80M215.60M-284.70M265.40M423.74M527.89M644.92M781.20M917.31M1.08B1.41B1.48B1.67B1.61B1.87B2.29B2.96B3.05B3.29B3.29B2.93B2.91B3.44B3.32B5.42B7.06B7.37B5.78B5.30B5.26B
Dividends Paid---2.60M3.40M4.70M5.10M5.90M10.50M9.90M10.02M11.68M13.52M15.33M17.73M21.55M24.59M34.27M38.26M41.72M52.21M61.32M86.40M52.10M227.70M354.10M399.80M378.30M433.40M750.70M615.00M742.00M818.00M821.00M768.00M878.00M
FCF to OCF52.86%-53.50%70.32%62.26%66.02%76.37%77.44%-85.93%63.33%82.72%86.76%90.79%90.67%88.78%89.93%91.10%90.15%89.58%89.53%89.57%87.26%86.58%84.99%87.62%86.51%83.26%83.59%85.48%83.92%87.26%84.52%86.48%80.70%79.19%81.98%
Dividend Paid to FCF---2.72%3.78%4.09%3.08%2.74%-3.69%3.73%2.36%2.21%2.10%1.96%1.93%1.99%1.74%2.31%2.30%2.59%2.80%2.68%2.92%1.71%6.91%10.77%13.63%13.01%12.61%22.64%11.35%10.50%11.10%14.20%14.50%16.69%

Earnings

Report DateOct 19, 1995Jan 25, 1996Apr 18, 1996Jul 18, 1996Oct 17, 1996Jan 30, 1997Apr 17, 1997Jul 17, 1997Oct 21, 1997Jan 29, 1998May 5, 1998Jul 16, 1998Oct 15, 1998Jan 28, 1999Apr 22, 1999Jul 22, 1999Oct 21, 1999Jan 27, 2000Apr 19, 2000Jul 20, 2000Oct 19, 2000Jan 24, 2001Apr 19, 2001Jul 19, 2001Oct 18, 2001Jan 24, 2002Apr 18, 2002Jul 18, 2002Oct 17, 2002Jan 30, 2003Apr 17, 2003Jul 17, 2003Oct 16, 2003Jan 29, 2004Apr 22, 2004Jul 22, 2004Oct 21, 2004Jan 27, 2005Apr 21, 2005Jul 21, 2005Oct 20, 2005Jan 26, 2006Apr 20, 2006Jul 20, 2006Oct 19, 2006Jan 25, 2007Apr 19, 2007Jul 19, 2007Oct 18, 2007Jan 24, 2008Apr 17, 2008Jul 17, 2008Oct 16, 2008Jan 26, 2009Apr 23, 2009Jul 23, 2009Oct 22, 2009Jan 28, 2010Apr 22, 2010Jul 22, 2010Oct 21, 2010Jan 27, 2011Apr 21, 2011Jul 21, 2011Oct 20, 2011Jan 31, 2012Apr 19, 2012Jul 19, 2012Oct 18, 2012Jan 29, 2013Apr 18, 2013Jul 18, 2013Oct 17, 2013Jan 28, 2014Apr 16, 2014Jul 17, 2014Oct 16, 2014Jan 27, 2015Apr 23, 2015Jul 23, 2015Oct 22, 2015Jan 26, 2016Apr 21, 2016Jul 25, 2016Oct 20, 2016Jan 31, 2017Apr 20, 2017Jul 20, 2017Oct 19, 2017Jan 30, 2018Apr 19, 2018Jul 19, 2018Oct 18, 2018Jan 29, 2019Apr 18, 2019Jul 18, 2019Oct 24, 2019Jan 30, 2020May 6, 2020Jul 23, 2020Oct 22, 2020Jan 28, 2021Apr 22, 2021Jul 22, 2021Oct 21, 2021Jan 27, 2022Apr 21, 2022Jul 21, 2022Oct 20, 2022Jan 24, 2023Apr 25, 2023Jul 25, 2023Oct 24, 2023Jan 30, 2024Apr 23, 2024Jul 23, 2024Oct 22, 2024Jan 29, 2025Apr 22, 2025Jul 22, 2025Oct 21, 2025Jan 28, 2026Apr 21, 2026Jul 21, 2026Oct 21, 2026
EPS Estimate0.060.060.050.060.070.070.060.080.080.090.080.090.100.110.090.110.120.130.120.140.140.150.140.160.150.130.140.160.180.190.160.190.210.240.210.270.300.330.280.330.350.400.330.390.410.470.380.460.480.560.440.530.560.520.360.440.430.540.440.530.550.660.570.670.700.780.710.800.790.870.770.850.830.960.800.940.891.040.931.041.041.271.031.220.821.030.840.970.951.160.941.091.081.271.021.161.151.251.021.091.361.881.772.052.152.542.662.342.252.552.262.021.881.911.711.571.572.161.641.641.722.191.941.841.92
EPS Actual0.060.060.060.070.070.070.070.080.090.090.080.100.100.110.100.110.120.130.120.140.140.150.140.160.150.130.140.170.190.200.160.200.220.240.230.280.310.330.290.340.350.410.330.400.420.480.390.470.490.560.450.550.570.560.360.450.450.560.480.560.600.670.610.690.730.810.730.840.770.870.750.870.840.960.810.930.901.040.931.081.051.271.081.250.871.050.850.991.001.190.991.151.101.281.071.191.161.281.051.441.722.082.522.462.392.692.762.762.562.872.362.052.022.091.921.721.712.141.881.801.892.232.061.94-
Surprise0.00%0.00%20.00%16.67%0.00%0.00%16.67%0.00%12.50%0.00%0.00%11.11%0.00%0.00%11.11%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%6.25%5.56%5.26%0.00%5.26%4.76%0.00%9.52%3.70%3.33%0.00%3.57%3.03%0.00%2.50%0.00%2.56%2.44%2.13%2.63%2.17%2.08%0.00%2.27%3.77%1.79%7.69%0.00%2.27%4.65%3.70%9.09%5.66%9.09%1.52%7.02%2.99%4.29%3.85%2.82%5.00%-2.53%0.00%-2.60%2.35%1.20%0.00%1.25%-1.06%1.12%0.00%0.00%3.85%0.96%0.00%4.85%2.46%6.10%1.94%1.19%2.06%5.26%2.59%5.32%5.50%1.85%0.79%4.90%2.59%0.87%2.40%2.94%32.11%26.47%10.64%42.37%20.00%11.16%5.91%3.76%17.95%13.78%12.55%4.42%1.49%7.45%9.42%12.28%9.55%8.92%-0.93%14.63%9.76%9.88%1.83%6.19%5.43%-
Timing-------Pre-marketPre-marketPre-marketPre-market---------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap157.95B
Enterprise Value177.96B
Trailing P/E39.70
Forward P/E23.81
PEG Ratio1.32
Price / Sales6.29
Price / Book2.96
EPS5.66
Book Value74.81
Revenue (TTM)25.11B
Gross Profit (TTM)14.75B
EBITDA8.03B
Profit Margin15.95%
Operating Margin19.78%
Return on Equity7.61%
Return on Assets3.95%
Shares Outstanding702.99M
Shares Float625.85M
Beta0.80
Dividend Yield0.72%
Dividend Rate1.60
Payout Ratio18.72%

Analyst Ratings

Strong Buy
Based on 25 analystsTarget 244.14
  • Strong Buy
    17
  • Buy
    5
  • Hold
    3

Ownership Breakdown

Institutions
84.30%
Insiders
10.96%
Retail / Other
4.74%

Top Institutional Holders

  • BlackRock Inc
    55.08M7.84%
  • Vanguard Capital Management, LLC
    41.38M5.89%
  • FMR Inc
    29.54M4.20%
  • State Street Corp
    28.46M4.05%
  • Wellington Management Company LLP
    16.32M2.32%
  • Capital Research & Mgmt Co - Division 3
    15.50M2.21%
  • Geode Capital Management, LLC
    14.28M2.03%
  • Vanguard Portfolio Management, LLC
    14.21M2.02%
  • JPMorgan Chase & Co
    12.19M1.73%
  • T. Rowe Price Associates, Inc.
    11.45M1.63%
  • Morgan Stanley - Brokerage Accounts
    11.35M1.61%
  • Capital Research Global Investors
    10.82M1.54%
  • NORGES BANK
    9.54M1.36%
  • Eagle Capital Management LLC
    9.36M1.33%
  • Jupiter Topco LLC
    7.65M1.09%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    20.25M2.88%
  • Vanguard 500 Index Investor
    16.74M2.38%
  • iShares Core S&P 500 ETF
    8.34M1.19%
  • Fidelity 500 Index
    8.18M1.16%
  • State Street® SPDR® S&P 500® ETF
    7.68M1.09%

Dividends

20262×
0.40Jun 26, 20260.40Mar 27, 2026
20254×
0.32Dec 26, 20250.32Sep 26, 20250.32Jun 27, 20250.32Mar 28, 2025
20244×
0.27Dec 27, 20240.27Sep 27, 20240.27Jun 28, 20240.27Mar 27, 2024
20234×
0.24Dec 28, 20230.27Oct 11, 20230.24Jun 29, 20230.24Mar 30, 2023
20224×
0.22Dec 29, 20220.22Sep 29, 20220.22Jun 23, 20220.22Mar 24, 2022
20214×
0.19Dec 29, 20210.19Sep 29, 20210.19Jun 24, 20210.19Mar 25, 2021
20202×
0.16Dec 24, 20200.16Sep 25, 2020

Stock Splits

  • Oct 2, 20231128:1000
  • Jul 5, 20161319:1000
  • Jun 14, 20102:1
  • May 21, 20042:1
  • Jun 1, 19982:1
  • Jan 23, 19952:1
  • Sep 9, 19872:1